ID 906 -
Lactobacillus rhamnosus ATCC53103 (LGG)
PL: Lactobacillus rhamnosus ATCC53103 (LGG)
EN: Lactobacillus rhamnosus LGG®
Pdf: Lactobacillus rhamnosus ATCC 53103
1. Charakterystyka żywności / składnika
The food constituent that is the subject of the health claims is Lactobacillus rhamnosus ATCC53103 (LGG).
The strain L. rhamnosus ATCC53103 (LGG) has been identified and characterised at species and strain level using both phenotypic and genotypic methods (Charteris et al., 2001; Janoir et al., unpublished; Tynkkynen et al., 1999). The Panel notes that culture collection numbers from the American Type Culture Collection (ATCC53103) and from the Belgian Co-ordinated Collections of Microorganisms (LMG 18243) are given.
The Panel considers that the food constituent, L. rhamnosus ATCC 53103 (LGG), which is the subject of the health claims, is sufficiently characterised.
2.1. Zdrowie przewodu pokarmowego (ID 906)
The claimed effect is “gastro-intestinal health”. The Panel assumes that the target population is the general population.
The claimed effect is not sufficiently defined, and no further details were provided in the proposed wordings. The Panel notes that the references provided addressed several effects (e.g. related to effects on gastro-intestinal symptoms, prevention of antibiotic-associated diarrhoea, treatment of acute diarrhoea, Helicobacter pylori eradication, or effects on subjects with a history of traveller‟s diarrhoea), and that it was not possible to establish the effect which is the target for the claim.
The Panel considers that the claimed effect is general and non-specific, and does not refer to any specific health claim as required by Regulation (EC) No 1924/2006.
Warunki i możliwe ograniczenia stosowania oświadczenia
Food matrix: at least 108 cfu/day
Capsules, tablets etc: at least 109 cfu/day
